When.com Web Search

  1. Ads

    related to: contrave vs qsymia xenical capsule

Search results

  1. Results From The WOW.Com Content Network
  2. 4 of the Top Prescription Weight Loss Pills & How They Work - AOL

    www.aol.com/4-top-prescription-weight-loss...

    Top Prescription Weight Loss Pills. Anti-obesity medications (AOMs) date back to the 1940s — well before modern regulations from the FDA (U.S. Food and Drug Administration) (FDA) were in place ...

  3. Naltrexone/bupropion - Wikipedia

    en.wikipedia.org/wiki/Naltrexone/bupropion

    Naltrexone/bupropion, sold under the brand name Contrave among others, is a fixed-dose combination medication for the management of chronic obesity in adults in combination with a reduced-calorie diet and increased physical activity. [4] [6] It contains naltrexone, an opioid antagonist, and bupropion, an aminoketone atypical antidepressant. [4]

  4. Anti-obesity medication - Wikipedia

    en.wikipedia.org/wiki/Anti-obesity_medication

    Orlistat (Xenical), the most commonly used medication to treat obesity and sibutramine (Meridia), a medication that was withdrawn due to cardiovascular side effects. Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control excess body fat.

  5. 15 Alternatives to Ozempic for Weight Loss - AOL

    www.aol.com/15-alternatives-ozempic-weight-loss...

    Like many Ozempic alternatives, Qsymia is FDA-approved for weight management in people with a BMI of 30 or more, or 27 or more with a weight-related condition. Research shows that treatment with ...

  6. What's the difference between Ozempic and Zepbound? Our ... - AOL

    www.aol.com/lifestyle/whats-difference-between...

    It's sold under the names Xenical and Alli. Phentermine-topiramate. Sold under the brand name Qsymia, it is a combination of the drugs phentermine and topiramate, which are taken orally. The ...

  7. Orexigen Therapeutics - Wikipedia

    en.wikipedia.org/wiki/Orexigen_Therapeutics

    The company has a single product, Contrave, approved for use in the United States in 2014. [ 2 ] [ 3 ] Contrave was designed not only to curb hunger but also reduce cravings. [ 3 ] Observation of the market performance of Qsymia and Belviq suggest overall low demand for pharmaceutical obesity therapies, calling into question earnings potential ...